[HTML][HTML] An overview of cutaneous T cell lymphomas

N Bagherani, BR Smoller - F1000Research, 2016 - ncbi.nlm.nih.gov
Cutaneous T cell lymphomas (CTCLs) are a heterogeneous group of extranodal non-
Hodgkin's lymphomas that are characterized by a cutaneous infiltration of malignant …

Therapeutic challenges in peripheral T-cell lymphoma

Y Luan, X Li, Y Luan, J Luo, Q Dong, S Ye, Y Li, Y Li… - Molecular Cancer, 2024 - Springer
Peripheral T-cell lymphoma (PTCL) is a rare and heterogeneous group of hematological
malignancies. Compared to our knowledge of B-cell tumors, our understanding of T-cell …

The microenvironment's role in mycosis fungoides and Sézary syndrome: from progression to therapeutic implications

A Pileri, A Guglielmo, V Grandi, SA Violetti, D Fanoni… - Cells, 2021 - mdpi.com
Background: Mycosis fungoides (MF) and Sezary Syndrome (SS) are the most common
cutaneous T-cell lymphomas. It has been hypothesized that the interaction between the …

Immune check point inhibitors in primary cutaneous T-cell lymphomas: biologic rationale, clinical results and future perspectives

G Roccuzzo, S Giordano, P Fava, A Pileri… - Frontiers in …, 2021 - frontiersin.org
Primary cutaneous T-cell lymphomas (PCTCL) are the most common types of cutaneous
lymphomas, with Mycosis fungoides as the most frequent subtype. Besides early stages …

Staphylococcus aureus enterotoxins induce FOXP3 in neoplastic T cells in Sézary syndrome

A Willerslev-Olsen, TB Buus, C Nastasi, E Blümel… - Blood cancer …, 2020 - nature.com
Sézary syndrome (SS) is a heterogeneous leukemic subtype of cutaneous T-cell lymphoma
(CTCL) with generalized erythroderma, lymphadenopathy, and a poor prognosis. Advanced …

Therapeutic reduction of cell-mediated immunosuppression in mycosis fungoides and Sézary syndrome

LJ Geskin, OE Akilov, S Kwon, M Schowalter… - Cancer Immunology …, 2018 - Springer
Tumor progression is associated with progressive immunosuppression mediated in part by T
regulatory cell (s)(Treg) and/or myeloid-derived suppressor cell (s)(MDSC). Development of …

Transcriptomic changes during stage progression of mycosis fungoides

MZX Xiao, D Hennessey, A Iyer… - British Journal of …, 2022 - academic.oup.com
Background Mycosis fungoides (MF) is the most common cutaneous T‐cell lymphoma,
which in the early patch/plaque stages runs an indolent course. However,~ 25% of patients …

Spatially Resolved Single-Cell Transcriptome Analysis of Mycosis Fungoides Reveals Distinct Biomarkers GNLY and FYB1 Compared With Psoriasis and Chronic …

JM Jung, CH Won, SE Chang, MW Lee, WJ Lee - Modern Pathology, 2025 - Elsevier
Early mycosis fungoides (MF) and inflammatory dermatoses including psoriasis and chronic
spongiotic dermatitis are often difficult to differentiate. We explored diagnostic markers …

[HTML][HTML] The Tumor Microenvironment as a Therapeutic Target in Cutaneous T Cell Lymphoma

LB Kwantwi, ST Rosen, C Querfeld - Cancers, 2024 - mdpi.com
Simple Summary Cutaneous T cell lymphomas (CTCLs) are a group of rare
lymphoproliferative malignancies manifesting in the skin. Cutaneous T cell lymphomas are …

Т-клеточные лимфомы кожи: современные данные патогенеза, клиники и терапии

ОМ Демина, ОЕ Акилов, АГ Румянцев - Онкогематология, 2018 - cyberleninka.ru
Т-клеточные лимфомы кожи (ТКЛК) представляют собой гетерогенную группу
экстранодальных неходжкинских лимфом, которые характеризуются инфильтрацией …